Avance Clinical
Sydney, Australia· Est.
Australian‑based CRO delivering fast, global early‑ and late‑phase clinical services for biotech sponsors.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Australian‑based CRO delivering fast, global early‑ and late‑phase clinical services for biotech sponsors.
OncologyCentral Nervous System (CNS)Rare DiseasesInfectious DiseasesRenalCardiometabolic
Technology Platform
AI‑enhanced site selection, RWD/RWE analytics, and proprietary GlobalReady/ClinicReady processes that integrate pre‑clinical planning with multi‑regional trial execution.
Opportunities
Expansion of U.S.
oncology capabilities and AI‑driven trial optimization can attract more early‑stage biotech sponsors seeking faster, cost‑effective development pathways.
Risk Factors
Dependence on Australian tax incentives and integration of acquired U.S.
operations could affect profitability and service consistency.
Competitive Landscape
Avance differentiates itself through a unified global platform and therapeutic centers of excellence, competing with large CROs like IQVIA and niche specialist firms.